Primum Non Nocere, Secundum Simulare: A New Era in Clinical Trials
Primum Non Nocere, Secundum Simulare: A New Era in Clinical Trials In silico trials (ISTs) and computational medicine are poised to transform medical device development and regulation, embodying the principle of "Do No Harm by Design". This talk explores how ISTs can address the limitations of traditional clinical trials, including high costs, lengthy timelines, and safety concerns. By s...
2025-08-28